A new in vitro/in vivo kinetic correlation method for nitrofurantoin matrix tablet formulations

Drug Development and Industrial Pharmacy

Volumn 26, Issue 7, 2000, Pages 737-743

  Ertan, G ^a   Karasulu, H Y ^a   Karasulu, E ^a   Ege, M A ^a   Kose T ^b   Guneri T ^a  

^a EGE UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

In vitro in vivo kinetic correlation; Matrix tablet; Nitrofurantoin

Indexed keywords

NITROFURANTOIN;

ARTICLE; CONTROLLED STUDY; DRUG EXCRETION; DRUG SOLUBILITY; DRUG TRANSFORMATION; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MATHEMATICAL ANALYSIS; MATRIX TABLET; TABLET FORMULATION; URINARY EXCRETION;

ANTI-INFECTIVE AGENTS, URINARY; CHEMISTRY, PHARMACEUTICAL; COMPUTER SIMULATION; HUMANS; NITROFURANTOIN; TABLETS; TISSUE DISTRIBUTION;

EID: 0034044278     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100101292     Document Type: Article

References (36)

1. J. P. Skelly, G. L. Amidon, W. H. Barr, L. Z. Benet, J. E. Carter, J. R. Robinson, V. P. Shah, and A. Yacobi, Pharm. Res., 7, 975 (1990).
2. S. Y. Lin, Y. H. Kao, and H. N. Chang, J. Pharm. Sci., 79, 326 (1990).
3. V. P. Shah, V. K. Prasad, C. Freeman, J. P. Skelly, and B. E. Cabana, J. Pharm. Sci., 72, 309 (1983).
4. A. El-Yazigi and R. J. Sawchuk, J. Pharm. Sci., 74, 161 (1985).
5. P. N. Hugucnin, H. W. Zulliger, and R. Niederer, Arzneim.-Forseh., 38, 305 (1988).
6. S. K. Das and B. K. Gupta, Drug Dev. Ind. Pharm., 14, 537 (1988).
7. L. H. Block and U. V. Banakar, Drug Dev. Ind. Pharm., 14, 2143 (1988).
8. K. Wingstrand, B. Abrahamson, and B. Edgar, Int. J. Pharm., 60, 151 (1990).
9. J. M. Aiache, N. Pierre, E. Beyssac, V. K. Prasad, and J. P. Skelly, J. Pharm. Sci., 78, 261 (1989).
10. Z. Hussein and M. Friedman, Pharm. Res., 7, 1167 (1990).
11. L. I. Harrison, A. K. Mitra, C. R. Kehe, N. M. Klinger, K. A. Wick, S. E. MCCarville, K. M. Cooper, S. F. Chang, P. J. Roddy, S. M. Berge, J. C. Kisicki, and R. J. Dockhorn, J. Pharm. Sci., 82, 644 (1993).
12. J. M. Cardot and E. Beyssac, Eur. J. Drug Metab. Pharmacokinet., 8, 113 (1993).
13. C. Caramella, F. Ferrari, M. C. Bonferroni, M. E. Sangalli, M. De Bernardi Di Valserra, F. Feletti, and M. R. Galmozzi, Drug Dispos., 14, 143 (1993).
14. H. Humbert, M. D. Cabiac, and H. Bosshardt, J. Pharm. Sci., 83, 131 (1994).
15. J. E. Polli, J. R. Crison, and G. L. Amidon, J. Pharm. Sci., 85, 753 (1996).
16. T. Prueksaritonont, L. M. Gorham, and K. C. Yeh, J. Pharm. Sci., 86, 1345 (1997).
17. A. Dunne, T. O'Hara, and J. Devane, J. Pharm. Sci., 86, 1245 (1997).
18. W. R. Gillespie and P. Veng-Pedersen, J. Pharmacokin. Biopharm., 13, 289 (1985).
19. K. K. H. Chan, F. Langenbucher, and M. Gibaldi, J. Pharm. Sci., 76, 446 (1987).
20. Short course on convolution, deconvolution and linear systems, announcement. Satellite of the Fifth European Congress on Biopharmaceutics and Pharmacokinetics, Brussels, April 19, 1993.
21. H. Y. Karasulu, G. Ertan, and T. Güneri, Eur. J. Drug. Metab. Pharmacokinet., 18, 108 (1993).
22. H. Y. Karasulu, G. Ertan, T. Köse, and T. Güneri, Eur. J. Drug. Metab. Pharmacokinet., 21, 27 (1996).
23. U.S. Pharmacopeial Convention, The United States Pharmacopeia 22, Author, Rockville, MD, 1990, p. 1788.
24. I. T. Agabeyoglu, Un Programme Dans la Langue Basique de Microcomputer Pour la Determination des données de Dissolution, 17th Semain Medical Balkanique, Istanbul, 1984 p. 327.
25. M. Concheiro, M. L. Labres, R. Vilo-Jato, R. Martinez, and J. Blanco, Drug Dev. Ind. Pharm., 13, 2301 (1987).
26. J. L. Vilo-Jato, A. Concheiro, and B. Seijo, Drug Dev. Ind. Pharm., 13, 1315 (1987).
27. Martindale, Extra Pharmacopoeia, 29th ed., Pharmaceutical Press, London, 1989, pp. 272-274.
28. D. E. Cadwallader, and H. W. Jun, Anal. Profiles Drug Subst., 5, 345 (1976).
29. M. Dey, R. Enever, M. Marino, J. Michelucci, D. Smith, R. Warner, and R. Weierstall, Int. J. Pharm., 49, 121 (1989).
30. R. Dietrich, R. Rrausse, G. Benedikt, and V. W. Steinijans, Arzneim.-Forsch., 38, 1229 (1988).
31. T. Dahl, T. Ling, J. Yee, and A. Bormeth, J. Pharm. Sci., 79, 389 (1990).
32. G. Ertan, E. Karasulu, D. Demirtas, M. Arici, and T. Güneri, J. Pharm. Pharmacol., 49, 229 (1997).
33. B. H. Chung and C. K. Shim, J. Pharm. Sci., 76, 784 (1987).
34. D. Brockmeier, H. J. Dangler, and D. Voegele, Eur. J. Clin. Pharmacol., 28, 291 (1985).
35. K. C. Cundy, I. L. Sue, G. C. Visor, J. Marshburn C. Nakamura, W. A. Lee, and J. P. Shaw, J. Pharm. Sci., 86, 1334 (1997).
36. K. J. Simons, E. M. Frith, and F. E. R. Simons, J. Pharm. Sci., 71, 505 (1982).